KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Exchange Rate Effect (2016 - 2025)

Biomarin Pharmaceutical (BMRN) has disclosed Exchange Rate Effect for 12 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect fell 51.32% year-over-year to $1.2 million, compared with a TTM value of -$2.5 million through Dec 2025, down 152.19%, and an annual FY2025 reading of -$2.5 million, down 152.19% over the prior year.
  • Exchange Rate Effect was $1.2 million for Q4 2025 at Biomarin Pharmaceutical, up from $739000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $3.3 million in Q2 2024 and bottomed at -$3.6 million in Q4 2023.
  • Average Exchange Rate Effect over 5 years is $179600.0, with a median of $150000.0 recorded in 2022.
  • Peak annual rise in Exchange Rate Effect hit 814.81% in 2023, while the deepest fall reached 5236.62% in 2023.
  • Year by year, Exchange Rate Effect stood at -$22000.0 in 2021, then soared by 422.73% to $71000.0 in 2022, then tumbled by 5236.62% to -$3.6 million in 2023, then surged by 168.66% to $2.5 million in 2024, then crashed by 51.32% to $1.2 million in 2025.
  • Business Quant data shows Exchange Rate Effect for BMRN at $1.2 million in Q4 2025, $739000.0 in Q3 2025, and -$3.1 million in Q2 2025.